Royal Bank of Canada
DRTX

Royal Bank of Canada’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Royal Bank of Canada’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-72,294
Closed -$917K – 6567
2014
Q3 		$917K Buy
72,294
+13,794
+24% +$206K ﹤0.01% 2913
2014
Q2 		$996K Buy
58,500
+5,050
+9% +$75.2K ﹤0.01% 2846
2014
Q1 		$720K Sell
53,450
-3,250
-6% -$42.6K ﹤0.01% 3053
2013
Q4 		$725K Buy
56,700
+9,563
+20% +$100K ﹤0.01% 3121
2013
Q3 		$426K Buy
47,137
+11,020
+31% +$91.4K ﹤0.01% 3504
2013
Q2 		$260K Buy
+36,117
New +$265K ﹤0.01% 3686

Royal Bank of Canada's DRTX Position: Q4 2014 in Review

Royal Bank of Canada sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 72,294 shares — an estimated $917K sold.

Royal Bank of Canada first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $996K in Q2 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

  • Royal Bank of Canada reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
  • Royal Bank of Canada sold 72,294 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $917K.
  • Royal Bank of Canada first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
  • Royal Bank of Canada's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $996K in Q2 2014.
  • 0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Royal Bank of Canada's 13F filing for Q4 2014, filed 17 Feb 2015.